Industry: Consumer Goods
Published Date: 2024-01-17
Pages: 97 Pages
Report ld: 2304285
Request Sample
Customized Report
Diabetic Insoles Market Size(US$)

CAGR 2024-2030
5.8%
Market Size,2030
USD 1,429.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Diabetic Insoles market was valued at US$ 962 million in 2023 and is anticipated to reach US$ 1429.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The Diabetic Insoles market is experiencing significant growth as the demand for specialized foot care solutions for individuals with diabetes continues to rise. Diabetic insoles, also known as diabetic foot orthotics or diabetic shoe inserts, are designed to provide support, cushioning, and pressure redistribution for diabetic patients who are at a higher risk of developing foot complications. The market growth is driven by factors such as the increasing prevalence of diabetes worldwide, the rising awareness about the importance of diabetic foot care, and the growing focus on preventing diabetic foot ulcers and related complications. Diabetic insoles offer benefits such as shock absorption, pressure relief, and enhanced stability, helping to reduce the risk of foot injuries, ulcers, and diabetic neuropathy-related issues. Key players in the market are investing in research and development to develop diabetic insoles with advanced materials, customized fitting options, and ergonomic designs that accommodate specific foot conditions. They are also focusing on collaborating with healthcare professionals to provide personalized solutions and improve patient outcomes. As the importance of diabetic foot care gains recognition and the diabetic population continues to grow, the diabetic insoles market is expected to witness substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Diabetic Insoles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Insoles.
MARKET SEGMENTATION
REPORT SCOPE
The Diabetic Insoles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Insoles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Insoles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Insoles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Insoles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Diabetic Insoles Market Overview
1.1 Product Overview and Scope of Diabetic Insoles
1.2 Diabetic Insoles Segment by Type
1.2.1 Global Diabetic Insoles Market Value Comparison by Type (2024-2030)
1.2.2 Single Density Diabetic Insoles
1.2.3 Dual Density Diabetic Insoles
1.2.4 Triple Density Diabetic Insoles
1.3 Diabetic Insoles Segment by Application
1.3.1 Global Diabetic Insoles Market Value by Application: (2024-2030)
1.3.2 Athletic Shoes
1.3.3 Boots
1.3.4 Casual Shoes
1.3.5 Others
1.4 Global Diabetic Insoles Market Size Estimates and Forecasts
1.4.1 Global Diabetic Insoles Revenue 2019-2030
1.4.2 Global Diabetic Insoles Sales 2019-2030
1.4.3 Global Diabetic Insoles Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetic Insoles Market Competition by Manufacturers
2.1 Global Diabetic Insoles Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetic Insoles Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetic Insoles Average Price by Manufacturers (2019-2024)
2.4 Global Diabetic Insoles Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetic Insoles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Insoles, Product Type & Application
2.7 Diabetic Insoles Market Competitive Situation and Trends
2.7.1 Diabetic Insoles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Insoles Players Market Share by Revenue
2.7.3 Global Diabetic Insoles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Insoles Retrospective Market Scenario by Region
3.1 Global Diabetic Insoles Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetic Insoles Global Diabetic Insoles Sales by Region: 2019-2030
3.2.1 Global Diabetic Insoles Sales by Region: 2019-2024
3.2.2 Global Diabetic Insoles Sales by Region: 2025-2030
3.3 Global Diabetic Insoles Global Diabetic Insoles Revenue by Region: 2019-2030
3.3.1 Global Diabetic Insoles Revenue by Region: 2019-2024
3.3.2 Global Diabetic Insoles Revenue by Region: 2025-2030
3.4 North America Diabetic Insoles Market Facts & Figures by Country
3.4.1 North America Diabetic Insoles Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetic Insoles Sales by Country (2019-2030)
3.4.3 North America Diabetic Insoles Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Insoles Market Facts & Figures by Country
3.5.1 Europe Diabetic Insoles Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetic Insoles Sales by Country (2019-2030)
3.5.3 Europe Diabetic Insoles Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Insoles Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Insoles Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetic Insoles Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetic Insoles Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Insoles Market Facts & Figures by Country
3.7.1 Latin America Diabetic Insoles Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetic Insoles Sales by Country (2019-2030)
3.7.3 Latin America Diabetic Insoles Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Insoles Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Insoles Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetic Insoles Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetic Insoles Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetic Insoles Sales by Type (2019-2030)
4.1.1 Global Diabetic Insoles Sales by Type (2019-2024)
4.1.2 Global Diabetic Insoles Sales by Type (2025-2030)
4.1.3 Global Diabetic Insoles Sales Market Share by Type (2019-2030)
4.2 Global Diabetic Insoles Revenue by Type (2019-2030)
4.2.1 Global Diabetic Insoles Revenue by Type (2019-2024)
4.2.2 Global Diabetic Insoles Revenue by Type (2025-2030)
4.2.3 Global Diabetic Insoles Revenue Market Share by Type (2019-2030)
4.3 Global Diabetic Insoles Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetic Insoles Sales by Application (2019-2030)
5.1.1 Global Diabetic Insoles Sales by Application (2019-2024)
5.1.2 Global Diabetic Insoles Sales by Application (2025-2030)
5.1.3 Global Diabetic Insoles Sales Market Share by Application (2019-2030)
5.2 Global Diabetic Insoles Revenue by Application (2019-2030)
5.2.1 Global Diabetic Insoles Revenue by Application (2019-2024)
5.2.2 Global Diabetic Insoles Revenue by Application (2025-2030)
5.2.3 Global Diabetic Insoles Revenue Market Share by Application (2019-2030)
5.3 Global Diabetic Insoles Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Algeos
6.1.1 Algeos Corporation Information
6.1.2 Algeos Description and Business Overview
6.1.3 Algeos Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Algeos Diabetic Insoles Product Portfolio
6.1.5 Algeos Recent Developments/Updates
6.2 AliMed
6.2.1 AliMed Corporation Information
6.2.2 AliMed Description and Business Overview
6.2.3 AliMed Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AliMed Diabetic Insoles Product Portfolio
6.2.5 AliMed Recent Developments/Updates
6.3 Physipod
6.3.1 Physipod Corporation Information
6.3.2 Physipod Description and Business Overview
6.3.3 Physipod Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Physipod Diabetic Insoles Product Portfolio
6.3.5 Physipod Recent Developments/Updates
6.4 PowerStep
6.4.1 PowerStep Corporation Information
6.4.2 PowerStep Description and Business Overview
6.4.3 PowerStep Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PowerStep Diabetic Insoles Product Portfolio
6.4.5 PowerStep Recent Developments/Updates
6.5 Implus(Spenco Medics)
6.5.1 Implus(Spenco Medics) Corporation Information
6.5.2 Implus(Spenco Medics) Description and Business Overview
6.5.3 Implus(Spenco Medics) Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Implus(Spenco Medics) Diabetic Insoles Product Portfolio
6.5.5 Implus(Spenco Medics) Recent Developments/Updates
6.6 Comfortland Medical
6.6.1 Comfortland Medical Corporation Information
6.6.2 Comfortland Medical Description and Business Overview
6.6.3 Comfortland Medical Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Comfortland Medical Diabetic Insoles Product Portfolio
6.6.5 Comfortland Medical Recent Developments/Updates
6.7 Atlantic Footcare
6.6.1 Atlantic Footcare Corporation Information
6.6.2 Atlantic Footcare Description and Business Overview
6.6.3 Atlantic Footcare Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Atlantic Footcare Diabetic Insoles Product Portfolio
6.7.5 Atlantic Footcare Recent Developments/Updates
6.8 MEGA
6.8.1 MEGA Corporation Information
6.8.2 MEGA Description and Business Overview
6.8.3 MEGA Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MEGA Diabetic Insoles Product Portfolio
6.8.5 MEGA Recent Developments/Updates
6.9 Orthofeet
6.9.1 Orthofeet Corporation Information
6.9.2 Orthofeet Description and Business Overview
6.9.3 Orthofeet Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Orthofeet Diabetic Insoles Product Portfolio
6.9.5 Orthofeet Recent Developments/Updates
6.10 Apexfoot.
6.10.1 Apexfoot. Corporation Information
6.10.2 Apexfoot. Description and Business Overview
6.10.3 Apexfoot. Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apexfoot. Diabetic Insoles Product Portfolio
6.10.5 Apexfoot. Recent Developments/Updates
6.11 Scholl’s Wellness
6.11.1 Scholl’s Wellness Corporation Information
6.11.2 Scholl’s Wellness Diabetic Insoles Description and Business Overview
6.11.3 Scholl’s Wellness Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Scholl’s Wellness Diabetic Insoles Product Portfolio
6.11.5 Scholl’s Wellness Recent Developments/Updates
6.12 Custom Feet Insoles
6.12.1 Custom Feet Insoles Corporation Information
6.12.2 Custom Feet Insoles Diabetic Insoles Description and Business Overview
6.12.3 Custom Feet Insoles Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Custom Feet Insoles Diabetic Insoles Product Portfolio
6.12.5 Custom Feet Insoles Recent Developments/Updates
6.13 Pedors
6.13.1 Pedors Corporation Information
6.13.2 Pedors Diabetic Insoles Description and Business Overview
6.13.3 Pedors Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pedors Diabetic Insoles Product Portfolio
6.13.5 Pedors Recent Developments/Updates
6.14 SoleTech
6.14.1 SoleTech Corporation Information
6.14.2 SoleTech Diabetic Insoles Description and Business Overview
6.14.3 SoleTech Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.14.4 SoleTech Diabetic Insoles Product Portfolio
6.14.5 SoleTech Recent Developments/Updates
6.15 Svorto
6.15.1 Svorto Corporation Information
6.15.2 Svorto Diabetic Insoles Description and Business Overview
6.15.3 Svorto Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Svorto Diabetic Insoles Product Portfolio
6.15.5 Svorto Recent Developments/Updates
6.16 CuraFoot
6.16.1 CuraFoot Corporation Information
6.16.2 CuraFoot Diabetic Insoles Description and Business Overview
6.16.3 CuraFoot Diabetic Insoles Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CuraFoot Diabetic Insoles Product Portfolio
6.16.5 CuraFoot Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Insoles Industry Chain Analysis
7.2 Diabetic Insoles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Insoles Production Mode & Process
7.4 Diabetic Insoles Sales and Marketing
7.4.1 Diabetic Insoles Sales Channels
7.4.2 Diabetic Insoles Distributors
7.5 Diabetic Insoles Customers
8 Diabetic Insoles Market Dynamics
8.1 Diabetic Insoles Industry Trends
8.2 Diabetic Insoles Market Drivers
8.3 Diabetic Insoles Market Challenges
8.4 Diabetic Insoles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Diabetic Insoles was estimated to be worth US$ 1128 million in 2025 and is projected to reach US$ 1665 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
The global Diabetic Insoles market was valued at US$ 1128 million in 2025 and is anticipated to reach US$ 1665 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 128
USD 2900.00
(Single User License)
The global Diabetic Insoles market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1583 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 110
USD 4250.00
(Single User License)
The global Diabetic Insoles market is projected to grow from US$ 1072 million in 2024 to US$ 1583 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-16
Pages: 178
USD 4900.00
(Single User License)
The global market for Diabetic Insoles was estimated to be worth US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1583 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 147
USD 3950.00
(Single User License)
The global market for Diabetic Insoles was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1583 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
The global Diabetic Insoles market is projected to grow from US$ 1019.2 million in 2024 to US$ 1429.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Published Date: 2024-04-12
Pages: 114
USD 4900.00
(Single User License)
The global market for Diabetic Insoles was estimated to be worth US$ 962 million in 2023 and is forecast to a readjusted size of US$ 1429.5 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
Published Date: 2024-01-10
Pages: 143
USD 3950.00
(Single User License)
The global market for Diabetic Insoles was estimated to be worth US$ 1128 million in 2025 and is projected to reach US$ 1665 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 150
The global Diabetic Insoles market was valued at US$ 1128 million in 2025 and is anticipated to reach US$ 1665 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-04-19
Pages: 128
The global Diabetic Insoles market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1583 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 110
The global Diabetic Insoles market is projected to grow from US$ 1072 million in 2024 to US$ 1583 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-16
Pages: 178
The global market for Diabetic Insoles was estimated to be worth US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1583 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 147
The global market for Diabetic Insoles was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1583 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-01-16
Pages: 104
The global Diabetic Insoles market is projected to grow from US$ 1019.2 million in 2024 to US$ 1429.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Published: 2024-04-12
Pages: 114
The global market for Diabetic Insoles was estimated to be worth US$ 962 million in 2023 and is forecast to a readjusted size of US$ 1429.5 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
Published: 2024-01-10
Pages: 143
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now